Case Study – Pricing for Survival in the Biopharma Industry: A Case Study of Acthar Gel and Questcor Pharmaceuticals
Volume 15, Number 4, 2017 Terence C. Burnham, Samuel Huang and Andrew W. Lo Recent cases of aggressive pricing behavior in the biopharmaceutical industry have raised serious concerns among payers and policymakers about industry ethics. However, these cases should not be confused with price increases motivated by challenging business conditions that ultimately lead to greater
As a library member, you must login and access JOIM through your library workstations. Please contact your librarian for assistance.
If you have any further questions or concerns, please email customerservice@joim.com